1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Global Preclinical Imaging Market - Introduction
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 Global Preclinical Imaging Market Landscape
5.1 Historical and Current Market Trends (2018-2023)
5.2 Market Forecast (2024-2032)
6 Global Preclinical Imaging Market - Breakup by Product
6.1 Modality
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2018-2023)
6.1.3 Market Segmentation
6.1.3.1 Optical Imaging Systems
6.1.3.2 Preclinical Nuclear Imaging Systems
6.1.3.3 Micro-Ultrasound Systems
6.1.3.4 Micro-MRI Systems
6.1.3.5 Micro-CT Systems
6.1.3.6 Preclinical Photoacoustic Imaging Systems
6.1.3.7 Preclinical Magnetic Particle Imaging (MPI) Systems
6.1.4 Market Forecast (2024-2032)
6.2 Reagent
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2018-2023)
6.2.3 Market Segmentation
6.2.3.1 Preclinical Optical Imaging Reagents
6.2.3.2 Preclinical Nuclear Imaging Reagents
6.2.3.3 Preclinical MRI Contrast Agents
6.2.3.4 Preclinical Ultrasound Contrast Agents
6.2.3.5 Preclinical CT Contrast Agents
6.2.4 Market Forecast (2024-2032)
6.3 Service
6.3.1 Overview
6.3.2 Historical and Current Market Trends (2018-2023)
6.3.3 Market Segmentation
6.3.4 Market Forecast (2024-2032)
6.4 Attractive Investment Proposition by Product
7 Global Preclinical Imaging Market - Breakup by End Use
7.1 Biotech Companies
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2018-2023)
7.1.3 Market Segmentation
7.1.4 Market Forecast (2024-2032)
7.2 Pharmaceutical Companies
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2018-2023)
7.2.3 Market Segmentation
7.2.4 Market Forecast (2024-2032)
7.3 Research Institutes
7.3.1 Overview
7.3.2 Historical and Current Market Trends (2018-2023)
7.3.3 Market Segmentation
7.3.4 Market Forecast (2024-2032)
7.4 Attractive Investment Proposition by End Use
8 Global Preclinical Imaging Market – Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Drivers
8.1.1.2 Historical and Current Market Trends (2018-2023)
8.1.1.3 Market Breakup by Product
8.1.1.4 Market Breakup by End Use
8.1.1.5 Key Players
8.1.1.6 Market Forecast (2024-2032)
8.1.2 Canada
8.1.2.1 Market Drivers
8.1.2.2 Historical and Current Market Trends (2018-2023)
8.1.2.3 Market Breakup by Product
8.1.2.4 Market Breakup by End Use
8.1.2.5 Key Players
8.1.2.6 Market Forecast (2024-2032)
8.2 Europe
8.2.1 Germany
8.2.1.1 Market Drivers
8.2.1.2 Historical and Current Market Trends (2018-2023)
8.2.1.3 Market Breakup by Product
8.2.1.4 Market Breakup by End Use
8.2.1.5 Key Players
8.2.1.6 Market Forecast (2024-2032)
8.2.2 France
8.2.2.1 Market Drivers
8.2.2.2 Historical and Current Market Trends (2018-2023)
8.2.2.3 Market Breakup by Product
8.2.2.4 Market Breakup by End Use
8.2.2.5 Key Players
8.2.2.6 Market Forecast (2024-2032)
8.2.3 United Kingdom
8.2.3.1 Market Drivers
8.2.3.2 Historical and Current Market Trends (2018-2023)
8.2.3.3 Market Breakup by Product
8.2.3.4 Market Breakup by End Use
8.2.3.5 Key Players
8.2.3.6 Market Forecast (2024-2032)
8.2.4 Italy
8.2.4.1 Market Drivers
8.2.4.2 Historical and Current Market Trends (2018-2023)
8.2.4.3 Market Breakup by Product
8.2.4.4 Market Breakup by End Use
8.2.4.5 Key Players
8.2.4.6 Market Forecast (2024-2032)
8.2.5 Spain
8.2.5.1 Market Drivers
8.2.5.2 Historical and Current Market Trends (2018-2023)
8.2.5.3 Market Breakup by Product
8.2.5.4 Market Breakup by End Use
8.2.5.5 Key Players
8.2.5.6 Market Forecast (2024-2032)
8.2.6 Others
8.2.6.1 Historical and Current Market Trends (2018-2023)
8.2.6.2 Market Forecast (2024-2032)
8.3 Asia Pacific
8.3.1 China
8.3.1.1 Market Drivers
8.3.1.2 Historical and Current Market Trends (2018-2023)
8.3.1.3 Market Breakup by Product
8.3.1.4 Market Breakup by End Use
8.3.1.5 Key Players
8.3.1.6 Market Forecast (2024-2032)
8.3.2 Japan
8.3.2.1 Market Drivers
8.3.2.2 Historical and Current Market Trends (2018-2023)
8.3.2.3 Market Breakup by Product
8.3.2.4 Market Breakup by End Use
8.3.2.5 Key Players
8.3.2.6 Market Forecast (2024-2032)
8.3.3 India
8.3.3.1 Market Drivers
8.3.3.2 Historical and Current Market Trends (2018-2023)
8.3.3.3 Market Breakup by Product
8.3.3.4 Market Breakup by End Use
8.3.3.5 Key Players
8.3.3.6 Market Forecast (2024-2032)
8.3.4 South Korea
8.3.4.1 Market Drivers
8.3.4.2 Historical and Current Market Trends (2018-2023)
8.3.4.3 Market Breakup by Product
8.3.4.4 Market Breakup by End Use
8.3.4.5 Key Players
8.3.4.6 Market Forecast (2024-2032)
8.3.5 Australia
8.3.5.1 Market Drivers
8.3.5.2 Historical and Current Market Trends (2018-2023)
8.3.5.3 Market Breakup by Product
8.3.5.4 Market Breakup by End Use
8.3.5.5 Key Players
8.3.5.6 Market Forecast (2024-2032)
8.3.6 Indonesia
8.3.6.1 Market Drivers
8.3.6.2 Historical and Current Market Trends (2018-2023)
8.3.6.3 Market Breakup by Product
8.3.6.4 Market Breakup by End Use
8.3.6.5 Key Players
8.3.6.6 Market Forecast (2024-2032)
8.3.7 Others
8.3.7.1 Historical and Current Market Trends (2018-2023)
8.3.7.2 Market Forecast (2024-2032)
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Drivers
8.4.1.2 Historical and Current Market Trends (2018-2023)
8.4.1.3 Market Breakup by Product
8.4.1.4 Market Breakup by End Use
8.4.1.5 Key Players
8.4.1.6 Market Forecast (2024-2032)
8.4.2 Mexico
8.4.2.1 Market Drivers
8.4.2.2 Historical and Current Market Trends (2018-2023)
8.4.2.3 Market Breakup by Product
8.4.2.4 Market Breakup by End Use
8.4.2.5 Key Players
8.4.2.6 Market Forecast (2024-2032)
8.4.3 Others
8.4.3.1 Historical and Current Market Trends (2018-2023)
8.4.3.2 Market Forecast (2024-2032)
8.5 Middle East and Africa
8.5.1 Market Drivers
8.5.2 Historical and Current Market Trends (2018-2023)
8.5.3 Market Breakup by Product
8.5.4 Market Breakup by End Use
8.5.5 Market Breakup by Country
8.5.6 Key Players
8.5.7 Market Forecast (2024-2032)
8.6 Attractive Investment Proposition by Region
9 Global Preclinical Imaging Market – Competitive Landscape
9.1 Overview
9.2 Market Structure
9.3 Market Share by Key Players
9.4 Market Player Positioning
9.5 Top Winning Strategies
9.6 Competitive Dashboard
9.7 Company Evaluation Quadrant
10 Profiles of Key Players
10.1 Aspect Imaging Ltd..
10.1.1 Business Overview
10.1.2 Product Portfolio
10.1.3 Business Strategies
10.1.4 SWOT Analysis
10.1.5 Major News and Events
10.2 AXT PTY LTD
10.2.1 Business Overview
10.2.2 Product Portfolio
10.2.3 Business Strategies
10.2.4 SWOT Analysis
10.2.5 Major News and Events
10.3 Bruker Corporation
10.3.1 Business Overview
10.3.2 Product Portfolio
10.3.3 Business Strategies
10.3.4 SWOT Analysis
10.3.5 Major News and Events
10.4 FUJIFILM Visualsonics, Inc. (Fujifilm Holdings Corporation)
10.4.1 Business Overview
10.4.2 Product Portfolio
10.4.3 Business Strategies
10.4.4 SWOT Analysis
10.4.5 Major News and Events
10.5 LI-COR Biosciences
10.5.1 Business Overview
10.5.2 Product Portfolio
10.5.3 Business Strategies
10.5.4 SWOT Analysis
10.5.5 Major News and Events
10.6 Mediso Ltd.
10.6.1 Business Overview
10.6.2 Product Portfolio
10.6.3 Business Strategies
10.6.4 SWOT Analysis
10.6.5 Major News and Events
10.7 MILabs B.V. (Rigaku Corporation)
10.7.1 Business Overview
10.7.2 Product Portfolio
10.7.3 Business Strategies
10.7.4 SWOT Analysis
10.7.5 Major News and Events
10.8 MR Solutions Ltd.
10.8.1 Business Overview
10.8.2 Product Portfolio
10.8.3 Business Strategies
10.8.4 SWOT Analysis
10.8.5 Major News and Events
10.9 PerkinElmer, Inc.
10.9.1 Business Overview
10.9.2 Product Portfolio
10.9.3 Business Strategies
10.9.4 SWOT Analysis
10.9.5 Major News and Events
10.10 Photon etc.
10.10.1 Business Overview
10.10.2 Product Portfolio
10.10.3 Business Strategies
10.10.4 SWOT Analysis
10.10.5 Major News and Events
10.11 TriFoil Imaging
10.11.1 Business Overview
10.11.2 Product Portfolio
10.11.3 Business Strategies
10.11.4 SWOT Analysis
10.11.5 Major News and Events
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
11 Global Preclinical Imaging Market - Industry Analysis
11.1 Drivers, Restraints, and Opportunities
11.1.1 Overview
11.1.2 Drivers
11.1.3 Restraints
11.1.4 Opportunities
11.1.5 Impact Analysis
11.2 Porters Five Forces Analysis
11.2.1 Overview
11.2.2 Bargaining Power of Buyers
11.2.3 Bargaining Power of Suppliers
11.2.4 Degree of Competition
11.2.5 Threat of New Entrants
11.2.6 Threat of Substitutes
11.3 Value Chain Analysis
12 Strategic Recommendations
13 Appendix